ConductScience.org, home

Paper20060370

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Potapenko IO and 8 others. Mol Oncol, 2010. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Papers, record 20060370. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20060370

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
PubMed
Journal
Mol Oncol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
3.72
iCite
Revised in PubMed
2021-10-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Potapenko IOIvan O
2Haakensen VDVilde D
3Lüders TTorben
4Helland AAslaug
5Bukholm IIda
6Sørlie TTherese
7Kristensen VNVessela N
8Lingjaerde OCOle C
9Børresen-Dale ALAnne-Lise

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BreastMajor topic
Breast NeoplasmsMajor topic
Disease ProgressionMajor topic
Gene Expression Regulation, NeoplasticMajor topic
PolysaccharidesMajor topic
Animals
Female
Glycosylation
Humans
Metabolic Networks and Pathways

Source PubMed

Download CSV of topics

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16200484Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.J Biol Chem1984https://conductscience.org/library/papers/6200484PubMed
215467392Regulation of integrin functions by N-glycans.Glycoconj J2004https://conductscience.org/library/papers/15467392PubMed
314695513The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1.Chembiochem2004https://conductscience.org/library/papers/14695513PubMed
47512965
Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity.
J Biol Chem1994https://conductscience.org/library/papers/7512965PubMed
512702551A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.Cancer Res2003https://conductscience.org/library/papers/12702551PubMed
66469974Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).J Biol Chem1984https://conductscience.org/library/papers/6469974PubMed
72583089Multiple domains of the large fibroblast proteoglycan, versican.EMBO J1989https://conductscience.org/library/papers/2583089PubMed
811351298Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells.Int J Cancer2001https://conductscience.org/library/papers/11351298PubMed
910433939Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.Am J Pathol1999https://conductscience.org/library/papers/10433939PubMed
101306307Multiple forms of mammalian sialidase: altered expression in carcinogenesis.Tohoku J Exp Med1992https://conductscience.org/library/papers/1306307PubMed
119190292Glycosphingolipid antigens and cancer therapy.Chem Biol1997https://conductscience.org/library/papers/9190292PubMed
1216940045N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.J Biol Chem2006https://conductscience.org/library/papers/16940045PubMed
1316904320Cell surface-associated mucins in signal transduction.Trends Cell Biol2006https://conductscience.org/library/papers/16904320PubMed
1415090732Sialidase and malignancy: a minireview.Glycoconj J2004https://conductscience.org/library/papers/15090732PubMed
1518384383Branched N-glycans regulate the biological functions of integrins and cadherins.FEBS J2008https://conductscience.org/library/papers/18384383PubMed
1611773621The glycosynapse.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/11773621PubMed
171628323Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells.Cell Motil Cytoskeleton1992https://conductscience.org/library/papers/1628323PubMed
1812634319All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.Glycobiology2003https://conductscience.org/library/papers/12634319PubMed
1911054714Lumican and decorin are differentially expressed in human breast carcinoma.J Pathol2000https://conductscience.org/library/papers/11054714PubMed
2017662123The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.Breast Cancer Res2007https://conductscience.org/library/papers/17662123PubMed

See all 120 referencesDownload CSV of references

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
41770230Glycan and glycoprotein signatures in tumor-induced liver alterations in a murine breast cancer model.Mol Genet Genomics2026https://conductscience.org/library/papers/41770230PubMed
41614767Evaluating the CRP Interactome: Insights into Possible Novel Roles in Cellular Signaling and Tumorigenicity.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41614767PubMed
41540482Functional regulation of GlycoRNA and progress in malignant tumors.J Transl Med2026https://conductscience.org/library/papers/41540482PubMed
41088964Altered Cell Surface N-Glycosylation Implicates Hypersialylation in Breast Cancer Brain Metastasis.J Proteome Res2025https://conductscience.org/library/papers/41088964PubMed
40442468Glycosylation in Cancer.Handb Exp Pharmacol2025https://conductscience.org/library/papers/40442468PubMed
40204713GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau.Nat Commun2025https://conductscience.org/library/papers/40204713PubMed
39999729Identification of the specific characteristics of neuroendocrine prostate cancer: Immune status, hub genes and treatment.Transl Oncol2025https://conductscience.org/library/papers/39999729PubMed
39628991When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression.Front Oncol2024https://conductscience.org/library/papers/39628991PubMed
39624801Roles of core fucosylation modification in immune system and diseases.Cell Insight2025https://conductscience.org/library/papers/39624801PubMed
38699667Targeting the stage-specific embryonic antigen (SSEA)-0 tumor neoantigen.Curr Trends Immunol2023https://conductscience.org/library/papers/38699667PubMed
38515194Decoding the glycoproteome: a new frontier for biomarker discovery in cancer.J Hematol Oncol2024https://conductscience.org/library/papers/38515194PubMed
36983711Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer.J Pers Med2023https://conductscience.org/library/papers/36983711PubMed
36806956The sialyl-Tn antigen synthase genes regulates migration-proliferation dichotomy in prostate cancer cells under hypoxia.Glycoconj J2023https://conductscience.org/library/papers/36806956PubMed
36789692Efficient TurboID-based proximity labelling method for identifying terminal sialic acid glycosylation in living cells.Acta Biochim Biophys Sin (Shanghai)2022https://conductscience.org/library/papers/36789692PubMed
35833116Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events.Front Immunol2022https://conductscience.org/library/papers/35833116PubMed
35797639High-Throughput Glycomic Methods.Chem Rev2022https://conductscience.org/library/papers/35797639PubMed
35744954An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.Molecules2022https://conductscience.org/library/papers/35744954PubMed
35454907Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study.Cancers (Basel)2022https://conductscience.org/library/papers/35454907PubMed
35432482A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.Front Genet2022https://conductscience.org/library/papers/35432482PubMed
35400524Pathological implication of protein post-translational modifications in cancer.Mol Aspects Med2022https://conductscience.org/library/papers/35400524PubMed

See all 86 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20060370

GET https://conductscience.org/api/papers/v1/20060370/references?page=2